National shortage of GLP-1 Receptor Agonist medications (semaglutide, dulaglutide and liraglutide)

There is currently a national shortage of GLP-1 Receptor Agonist medications (semaglutide, dulaglutide and liraglutide).

The supply issue is expected to continue until mid 2024. During this time patients may not be able to obtain their medication or may be issued a lower dose.

Our apologies. Patients who are prescribed these medications will receive direct correspondence with further details shortly.